The Ovary

  • Mortimer B. Lipsett
  • Griff T. Ross


Over the years, considerable effort has been devoted to defining the subsets of the population of women with secondary amenorrhea. It has long been recognized that some of these women had ample evidence of estrogen secretion, whereas others could be categorized, by vaginal smear and urinary estrogen determinations, as belonging to a low-estrogen group. Systematic studies of women with secondary amenorrhea have now revealed the interrelationships between serum estrogen concentrations and other diagnostic tests.


Luteinizing Hormone Human Chorionic Gonadotropin Polycystic Ovary Syndrome Gonadal Dysgenesis Plasma Progesterone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kletzky, O. A., Jr., Davajan, V., Nakamura, R. M., Thorneycroft, I. H., and Mishell, D. R., 1975, Clinical categorization of patients with secondary amenorrhea using progesterone-induced uterine bleeding and measurement of serum gonadotropin levels, Am. J. Obstet. Gynecol. 121:695–703.PubMedGoogle Scholar
  2. 2.
    Kletzky, O. A., Davajan, V., Nakamura, R. M., and Mishell, D. R., Jr., 1975, Classification of secondary amenorrhea based on distinct hormonal patterns, J. Clin. Endocrinol. Metab. 41:660–668.PubMedGoogle Scholar
  3. 3.
    Vaitukaitis, J., Becker, R., Hansen, J., and Mecklenburg, R., 1974, Altered LRF responsiveness in amenorrheic women, J. Clin. Endocrinol. Metab. 39:1005–1011.PubMedGoogle Scholar
  4. 4.
    Morley, J. E., Distiller, L. A., Sagel, J., and Oxenham, E., 1975, The diagnostic application of clomiphene citrate and luteinizing hormone-releasing hormone in patients with amenorrhoea and oligomenorrhoea, Int. J. Feral. 20:225–227.Google Scholar
  5. 5.
    Kistner, R. W., 1975, Induction of ovulation with clomiphene citrate, in: Progress in Infertility, 2nd Ed. (S. J. Behrman and R. W. Kistner, eds.), pp. 509–536, Little, Brown and Co., Boston.Google Scholar
  6. 6.
    Goldenberg, R. L., Grodin, J. M., Vaitukaitis, J. L., and Ross, G. T., 1973, Withdrawal bleeding and luteinizing hormone secretion following progesterone in women with amenorrhea, Am. J. Obstet. Gynecol. 115:193–196.PubMedGoogle Scholar
  7. 7.
    Argonz, J., and del Castillo, E. B., 1953, A syndrome characterized by estrogenic insufficiency, galactorrhea and decreased urinary gonadotropin, J.Clin. Endocrinol. Metab. 13:79–87.PubMedGoogle Scholar
  8. 8.
    Franks, S., Murray, M. A. F., Jequier, A. M., Steele, S. J., Nabarro, J. D. N., and Jacobs, H. S., 1975, Incidence and significance of hyperprolactinaemia in women with amenorrhoea, Clin. Endocrinol. 4:597–607.Google Scholar
  9. 9.
    Hull, M. G. R., Murray, M. A. F., Franks, S., Lieberman, B. A., and Jacobs, H. S., 1976, Female hypogonadism—therapy oriented diagnosis of secondary amenorrhoea, in: Endocrine Function of the Human Ovary (M. Serio and V. H. T. James, eds.), pp. 245–259, Academic Press, London.Google Scholar
  10. 10.
    Jacobs, H. S., Franks, S., Murray, M. A. F., Hull, M. G. R., Steele, S. J., and Nabarro, J. D. N., 1976, Clinical and endocrine features of hyperprolacti-naemic amenorrhoea, Clin. Endocrinol. 5:439–454.Google Scholar
  11. 11.
    Kleinberg, D. L., Noel, G. L., and Frantz, A. G., 1977, Galactorrhea: A study of 235 cases, including 48 with pituitary tumors, N. Engl. J. Med. 296:589–600.PubMedGoogle Scholar
  12. 12.
    Bohnet, H. G., Dahlén, H. G., Wuttke, W., and Schneider, H. P. G., 1976, Hyperprolactinemic anovulatory sny drome, J.Clin. Endocrinol. Metab. 43:132–143.Google Scholar
  13. 13.
    Jewelewicz, R., Dyrenfurth, I., Warren, M., Frantz, A. G., and Vande Wiele, R. L., 1974, Effect of thyrotropin-releasing hormone (TRH) upon the menstrual cycle in women, J. Clin. Endocrinol. Metab. 39:387–390.PubMedGoogle Scholar
  14. 14.
    Corenblum, B., Pairaudeau, N., and Shewchuk, A. B., 1976, Prolactin hypersecretion and short luteal phase defects, Obstet. Gynecol. 47:486–488.PubMedGoogle Scholar
  15. 15.
    McNatty, K. P., Sawers, R. S., and McNeilly, A. S., 1974, A possible role for prolactin in control of steroid secretion by the human Graafian follicle, Nature (London) 250:653–655.Google Scholar
  16. 16.
    McNatty, K. P., Hunter, W. M., McNeilly, A. S., and Sawers, R. S., 1975, Changes in the concentration of pituitary and steroid hormones in the follicular fluid of human Graffian follicles through the menstrual cycle, J. Endocrinol. 64:555–571.PubMedGoogle Scholar
  17. 17.
    del Pozo, E., Goldstein, M., Friesen, H., Brun del Re, R., and Eppenberger, V., 1975, Lack of action of prolactin suppression on the regulation of the human menstrual cycle, Am. J. Obstet. Gynecol. 123:719–723.PubMedGoogle Scholar
  18. 18.
    Glass, M. R., Shaw, R. W., Williams, T. W., Butt, W. R., Logan-Edwards, R., and London, D. R., 1976, The control of gonadotrophin release in women with hyperprolactinaemic amenorrhoea: Effect of oestrogen and progesterone on the LH and FSH response to LHRH, Clin. Endocrinol. 5:521–530.Google Scholar
  19. 19.
    Aono, T., Miyaké, A., Shioji, T., Kinugasa, T., Onishi, T., and Kurachi, K., 1976, Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome, J.Clin. Endocrinol. Metab. 42:696–702.PubMedGoogle Scholar
  20. 20.
    Zaraté, A., Canales, E. S., Soria, J., Leon, C., Garrido, J., and Fonseca, E., 1974, Refactory postpartum ovarian response to gonadal stimulation in nonlactating women, Obstet. Gynecol. 44:819–822.PubMedGoogle Scholar
  21. 21.
    Canales, E. S., Zaraté, A., Soria, J., Gonzalez, J., Levinson, G., and Fonesca, E., 1976, Further observations on postpartum ovarian refractoriness: Effect of gonadal stimulation in women receiving bromocryptine, Clin. Endocrinol. 5:127–130.Google Scholar
  22. 22.
    Nakano, R., Mori, A., Kayashima, F., Washio, M., and Tojo, S., 1975, Ovarian response to exogenously administered human gonadotropins during the postpartum period, Am. J. Obstet. Gynecol. 121:187–192.PubMedGoogle Scholar
  23. 23.
    Andreassen, B., and Tyson, J. E., 1974, Role of the hypothalamic-pituitary-ovarian axis in puerperal infertility, J.Clin. Endocrinol. Metab. 42:1114–1122.Google Scholar
  24. 24.
    Mroueh, A. M., and Siler-Khodr, T. M., 1976, Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: Restoration of ovarian function with bromocryptine, J.Clin. Endocrinol. Metab. 43:1398–1401.PubMedGoogle Scholar
  25. 25.
    Archer, D. F., and Josimovich, J. B., 1976, Ovarian response to exogenous gonadotropins in women with elevated serum prolactin, Obstet. Gynecol. 48:155–157.PubMedGoogle Scholar
  26. 26.
    Keye, W. R., Jr., and Jaffe, R. B., 1976, Changing patterns of FSH and LH response to gonadotropin-releasing hormone in the puerperium, J. Clin. Endocrinol. Metab. 42:1133–1138.PubMedGoogle Scholar
  27. 27.
    Seppälä, M., Hirvonen, E., and Ranta, T., 1976, Bromocriptine treatment of secondary amenorrhoea, Lancet 1:1154–1159.PubMedGoogle Scholar
  28. 28.
    Mcintosh, E. N., 1976, Treatment of women with the galactorrhea-amenor-rhea syndrome with pyridoxine (vitamin B6), J. Clin. Endocrinol. Metab. 42:1192–1195.PubMedGoogle Scholar
  29. 29.
    Zacur, H. A., Chapanis, N. P., Lake, C. R., Ziegler, M., and Tyson, J. E., 1976, Galactorrhea-amenorrhea: Psychological interaction with neuroendocrine function, Am. J. Obstet. Gynecol. 125:859–862.PubMedGoogle Scholar
  30. 30.
    Tolis, G., and Naftolin, F., 1976, Induction of menstruation with bromo-cryptine in patients with euprolactinemic amenorrhea, Am. J. Obstet. Gynecol 126:428–429.Google Scholar
  31. 31.
    Seppälä, M., Unnérus, H.-A., Hirvonen, E., and Ranta, T., 1976, Bromocriptine increases plasma estradiol-17β concentration in amenorrhea patients with normal serum prolactin, J.Clin. Endocrinol. Metab. 43:474–477.Google Scholar
  32. 32.
    Bassi, F., Giusti, G., Borsi, L., Cattaneo, S., Giannotti, P., Forti, G., Pazzagli, M., Vigiani, C., and Serro, M., 1977, Plasma androgens in women with hyperprolactinemic amenorrhoea, Clin. Endocrinol. 6:5–10.Google Scholar
  33. 33.
    Boyns, A. R., Cole, E. N., Golder, M. P., Danutra, V., Harper, M. E., Bromnsey, B., Cowley, T., Jones, G. E., and Griffiths, K., 1972, Prolactin studies with the prostate, in: Prolactin and Carcinogensis (A. R. Boyns and K. Griffiths, eds.), pp. 207–216. Alpha Omega Alpha, Cardiff, Wales.Google Scholar
  34. 34.
    Seppälä, M., Hirvonen, E., Unnérus, H.-A., Ranta, T., and Laatikainin, T., 1976, Prolactin and testosterone: Independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine, J.Clin. Endocrinol. Metab. 43:198–200.Google Scholar
  35. 35.
    Marshall, J. C., Reed, P. I., and Gordon, H., 1976, Luteinizing hormone secretion in patients presenting with post-oral contraceptive amenorrhoea: Evidence for a hypothalamic feedback abnormality, Clin. Endocrinol. 5:131–143.Google Scholar
  36. 36.
    Gómez, F., Reyes, F. I., and Faiman, C., 1977, Nonpuerperal galactorrhea and hyperprolactinemia, Am. J. Med. 62:648–660.PubMedGoogle Scholar
  37. 37.
    Yen, S. S. C., Vela, P., and Rankin, J., 1970, Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease, J. Clin. Endocrinol. Metab. 30:435–442.PubMedGoogle Scholar
  38. 38.
    Gambrell, R. D., Jr., Greenblatt, R. B., and Mahesh, V. B., 1973, Inappropriate secretion of LH in Stein-Leventhal syndrome, Obstet. Gynecol. 42:429–440.PubMedGoogle Scholar
  39. 39.
    Berger, M. J., Taymor, M. L., and Patton, W. C., 1975, Gonadotropin levels and secretory patterns in patients with typical and atypical polycystic ovarian disease, Fertil. Steril. 26:619–626.PubMedGoogle Scholar
  40. 40.
    Patton, W. C., Berger, M. J., Thompson, I. E., Chong, A. P., Grimes, E. M., and Taymor, M. L., 1975, Pituitary gonadotropin responses to synthetic luteinizing hormone-releasing hormone in patients with typical and atypical polycystic ovary disease, Am. J. Obstet. Gynecol. 121:382–386.PubMedGoogle Scholar
  41. 41.
    Nillius, S. J., and Wide, L., 1971, Induction of a midcycle-like peak of luteinizing hormone in young women by exogenous oestradiol-17β, J.Obstet. Gynaecol. Br. Commonw. 78:822–827.PubMedGoogle Scholar
  42. 42.
    Givens, J. R., Andersen, R. N., Umstot, E. S., and Wiser, W. L., 1976, Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels, Obstet. Gynecol 47:388–394.PubMedGoogle Scholar
  43. 43.
    Shaw, R. W., Duignan, N. M., Butt, W. R., Logan-Edwards, R., and London, D. R., 1975, Hypothalamic-pituitary relationships in the polycystic ovary syndrome. Serum gonadotrophin levels following injection of oestradiol benzoate, Br. J. Obstet. Gynaecol. 82:952–957.PubMedGoogle Scholar
  44. 44.
    Duignan, N. M., Shaw, R. W., Rudd, B. T., Holder, G., Williams, J. W., Butt, W. R., Logan-Edwards, R., and London, D. R., 1975, Sex hormone levels and gonadotrophin release in the polycystic ovary syndrome, Clin. Endocrinol. 4:287–295.Google Scholar
  45. 45.
    Shaw, R. W., Duignan, N. M., Butt, W. R., Logan-Edwards, R., and London, D. R., 1976, Modification by sex steroids of LHRH response in the polycystic ovary syndrome, Clin. Endocrinol. 5:495–502.Google Scholar
  46. 46.
    Katz, M., and Carr, P. J., 1976, Abnormal luteinizing hormone response patterns to synthetic gonadotrophin-releasing hormone in patients with polycystic ovarian syndrome, J.Endocrinol. 70:163–171.PubMedGoogle Scholar
  47. 47.
    Lawrence, D. M., McGarrigle, H. H. G., Radwańska, E., and Swyer, G. I. M., 1976, Plasma testosterone and androstenedione levels during monitored induction of ovulation in infertile women with “simple” amenorrhoea and with the polycystic ovary syndrome, Clin. Endocrinol. 5:609–618.Google Scholar
  48. 48.
    Judd, H. L., Rigg, L. A., Anderson, D. C., and Yen, S. S. C., 1976, The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome, J. Clin. Endocrinol. Metab. 43:347–355.PubMedGoogle Scholar
  49. 49.
    Cox, R. L., and Shearman, R. P., 1961, Abnormal excretion of pregnan-etriolone A5-pregnenetriol in the Stein-Leventhal syndrome, J.Clin. Endocrinol. Metab. 21:586–590.PubMedGoogle Scholar
  50. 50.
    Maschler, I., Salzberger, M., and Finkelstein, M., 1975, 11/3-Hydroxylase with affinity to C-21-deoxysteroids from ovaries of patients with polycystic ovary syndrome, J.Clin. Endocrinol. Metab. 41:999–1002.PubMedGoogle Scholar
  51. 51.
    Yussman, M. A., and Taymor, M. L., 1970, Serum levels of follicle stimulating hormone and luteinizing hormone and of plasma progesterone related to ovulation by corpus luteum biopsy, J.Clin. Endocrinol. Metab. 30:396–399.PubMedGoogle Scholar
  52. 52.
    Thorneycroft, I. H., Sribyatta, B., Tom, W. K., Nakamura, R. M., and Mishell, D. R., Jr. 1974, Measurement of serum LH, FSH, progesterone, 17-hydroxyprogesterone and estradiol-17β levels at 4-hour intervals during the periovulatory phase of the menstrual cycle, J.Clin. Endocrinol. Metab. 39:754–758.PubMedGoogle Scholar
  53. 53.
    Abraham, G. E., Odell, W. D., Swerdloff, R. S., and Hopper, K., 1972, Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone and estradiol-17β during the menstrual cycle, J.Clin. Endocrinol. Metab. 34:312–318.PubMedGoogle Scholar
  54. 54.
    Laborde, N., Carril, M., Cheviakoff, S., Croxatto, H. D., Pedroza, E., and Rosner, J. M., 1976, The secretion of progesterone during the periovulatory period in women with certified ovulation, J.Clin. Endocrinol. Metab. 43:1157–1163.PubMedGoogle Scholar
  55. 55.
    Chattoraj, S. C., Rankin, J. C., Turner, A. K., and Lowe, E. W., 1976, Urinary progesterone as an index of ovulation and corpus luteal function, J.Clin. Endocrinol. Metab. 43:1402–1405.PubMedGoogle Scholar
  56. 56.
    Sobrinho, L. G., Kase, N. G., and Grunt, J. A., 1972, Changes in adrenocortical function of patients with gonadal dysgenesis after treatment with estrogen, J.Clin. Endocrinol. Metab. 33:110–114.Google Scholar
  57. 57.
    Abraham, G. E., and Maroulis, G. B., 1975, Effect of exogenous estrogen on serum pregnenolone, Cortisol and androgens in post-ménopausal women, Obstet. Gynecol. 45:271–274.PubMedGoogle Scholar
  58. 58.
    Anderson, D. C., and Yen, S. S. C., 1976, Effects of estrogens on adrenal 3/3-hydroxysteroid dehydrogenase in ovariectomized women, J.Clin. Endocrinol. Metab. 43:561–570.PubMedGoogle Scholar
  59. 59.
    Ascheim, S., and Zondek, B., 1927, Hypophysenvorderlappenhormon und Ovarialhormon im Harn von Schwangeren, Klin. Wochenschr. 6:1322.Google Scholar
  60. 60.
    Canfield, R. E., Agosto, G. M., and Bell, J. J., 1970, Studies of the chemistry of human chorionic gonadotrophin, in: Gonadotropins and Ovarian Development (W. R. Butt, A. C. Crooke, and M. Ryle, eds.), pp. 161–170, E. &S. Livingstone, Edinburgh.Google Scholar
  61. 61.
    Morgan, F. J., and Canfield, R. E., 1971, Nature of the subunits of human chorionic gonadotropin, Endocrinology 88:1045–1053.PubMedGoogle Scholar
  62. 62.
    Bellisario, R., Carlsen, R. B., and Bahl, O. P., 1973, Human chorionic gonadotropin. linear amino acid sequence of the α subunit, J. Biol. Chem. 248:6796–6809.PubMedGoogle Scholar
  63. 63.
    Morgan, F. J., Birken, S., and Canfield, R. E., 1975, The amino acid sequence of human chorionic gonadotropin. The a subunit and β subunit, J.Biol Chem. 250:5247–5258.PubMedGoogle Scholar
  64. 64.
    Shome, B., and Parlow, A. F., 1974, Human follicle stimulating hormone (hFSH): First proposal for the amino acid sequence of the α-subunit (hFSHα) and first demonstration of its identity with the α-subunit of human luteinizing hormone (hLHα), J. Clin. Endocrinol. Metab. 39:199–202.PubMedGoogle Scholar
  65. 65.
    Shome, B., and Parlow, A. F., 1973, The primary structure of the hormone-specific, beta subunit of human pituitary luteinizing hormone (hLH), J. Clin. Endocrinol. Metab. 36:618–621.PubMedGoogle Scholar
  66. 66.
    Closset, J., Hennen, G., and Lequin, R. M., 1973, Human luteinizing hormone. The amino acid sequence of the β subunit, FEBS Lett. 29:97–100.PubMedGoogle Scholar
  67. 67.
    Shome, B., and Parlow, A. F., 1974, Human follicle stimulating hormone: First proposal for the amino acid sequence of the hormone-specific, β subunit (hFSH/3), J.Clin. Endocrinol. Metab. 39:203–205.PubMedGoogle Scholar
  68. 68.
    Morgan, F. J., Kammerman, S., and Canfield, R. E., 1972, Studies in the structure and activity of HCG, in: Gonadotropins (B. B. Saxena, C. G. Beling, and H. M. Gandy, eds.) p. 211, Wiley-Interscience, New York.Google Scholar
  69. 69.
    Morgan, F. J., Canfield, R. E., Vaitukaitis, J. L., and Ross, G. T., 1974, Properties of the subunits of human chorionic gonadotropin, Endocrinology 94:1601–1606.PubMedGoogle Scholar
  70. 70.
    Canfield, R. E., and Ross, G. T., 1976, A new reference preparation of human chorionic gonadotropin and its subunits, Bull. W.H.O. 54:463–470.PubMedGoogle Scholar
  71. 71.
    Louvet, J.-R, Harman, S. M., Nisula, B. C., Ross, G. T., Birken, S., and Canfield, R., 1976, Follicle stimulating activity of human chorionic gonadotropin: Effect of dissociation and recombination of subunits, Endocrinology 99:1126–1128.PubMedGoogle Scholar
  72. 72.
    Nisula, B. C., Morgan, F. J., and Canfield, R. E., 1974, Evidence that chorionic gonadotropin has intrinsic thyrotropic activity, Biochem. Biophys, Res. Commun. 59:86–91.Google Scholar
  73. 73.
    Van Hall, E. V., Vaitukaitis, J. L., Ross, G. T., Hickman, J. W., and Ashwell, G., 1971, Immunological and biological activity of HCG following progressive desialylation, Endocrinology 88:456–464.PubMedGoogle Scholar
  74. 74.
    Van Hall, E. V., Vaitukaitis, J. L., Ross, G. T., Hickman, J. W., and Ashwell, G., 1971, Effects of progressive desialylation on the rate of disappearance of immunoreactive HCG from plasma in rats, Endocrinology 89:11–15.PubMedGoogle Scholar
  75. 75.
    Birken, S., and Canfield, R. E., 1974, Labelled asialo-human chorionic gonadotropin as a liver-scanning agent, J.Nucl. Med. 15:1176–1178.PubMedGoogle Scholar
  76. 76.
    Goverde, B. C., Veenkamp, F.J. N., and Homan, J. D. H., 1968, Studies on human chorionic gonadotrophin. II. Chemical composition and its relation to biological activity, Acta Endocrinol. (Copenhagen) 59:105–119.Google Scholar
  77. 77.
    Moyle, W. R., Bahl, O. R., and März, L., 1975, Role of the carbohydrate of human chorionic gonadotropin in the mechanism of hormone action, J.Biol. Chem. 250:9163–9169.PubMedGoogle Scholar
  78. 78.
    Vaitukaitis, J. L., Braunstein, G. D., and Ross, G. T., 1972, A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone, Am. J. Obstet. Gynecol. 113:751–758.PubMedGoogle Scholar
  79. 79.
    Chen, H.-C, Hodgen, G. D., Matsuura, S., Iin, L. J., Gross, E., Reichert, L. E., Jr., Birken, S., Canfield, R. E., and Ross, G. T., 1976, Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin, Proc. Natl. Acad. Sci. U.S.A. 73:2885–2889.PubMedGoogle Scholar
  80. 80.
    Franchimont, P., and Reuter, A., 1972, Evidence of a- and /3-subunits of HCG in serum and urines of pregnant women, in: Structure-activity Relationship of Protein and Polypeptide Hormones (M. Margoulies and F. C. Greenwood, eds.), pp. 381–387, Excerpta Media, The Netherlands.Google Scholar
  81. 81.
    Vaitukaitis, J. L., 1974, Changing placental concentrations of human chorionic gonadotropin and its subunits during gestation. J. Clin. Endocrinol. Metab. 38:755–760.PubMedGoogle Scholar
  82. 82.
    Hagen, C., and McNeilly, A. S., 1975, The gonadotropic hormones and their subunits in human maternal and fetal circulation at delivery, Am. J. Obstet. Gynecol. 121:926–930.PubMedGoogle Scholar
  83. 83.
    Kaplan, S. L., Grumbach, M. M., and Aubert, M. L., 1976, α and β glycoprotein hormone subunits (hLH, hFSH, hCG) in the serum and pituitary of the human fetus, J. Clin. Endocrinol. Metab. 42:995–998.PubMedGoogle Scholar
  84. 84.
    Vaitukaitis, J. L., and Ebersole, E. R., 1976, Evidence for altered synthesis of human chorionic gonadotropin in gestational trophoblastic tumors, J.Clin. Endocrinol. Metab. 42:1048–1055.PubMedGoogle Scholar
  85. 85.
    Vaitukaitis, J. L., Ross, G. T., Braunstein, G. D., and Rayford, P. L., 1976, Gonadotropins and their subunits: Basic and clinical studies, Recent Prog. Horm. Res. 32:289–331.PubMedGoogle Scholar
  86. 86.
    Acevedo, H. F., Shlifkin, M., Pouchet, G. R., and Rackshan, M., 1977, Human chorionic gonadotropin in cancer cells. 1. Identification in in vitro and in vivo cancers, in: Proceedings of the Third International Symposium on Detection and Prevention of Cancer (H. E. Niebert, ed.), Marcel Dekker, New York.Google Scholar
  87. 87.
    Shlifkin, M., Acevedo, H. F., Pardo, M., Pouchet, G. R., and Rackshan, M., 1977, Human chorionic gonadotropin in cancer cells. IL Ultrastructural localization, in: Proceedings of the Third International Symposium on Detection and Prevention of Cancer (H. E. Niebert, ed.), Marceli Dekker, New York.Google Scholar
  88. 88.
    Naughton, M. A., Merrill, D. A., McManus, L. M., Fink, L. N., Berman, E., White, M. J., and Martinez-Hernandez, A., 1975, Tocalization of the β chain of human chorionic gonadotropin on human tumor cells and placental cells, Cancer Res. 35:1887–1890.PubMedGoogle Scholar
  89. 89.
    Weintraub, B. D., and Rosen, S. W., 1973, Ectopic production of the isolated beta subunit of human chorionic gonadotropin, J.Clin. Invest. 52:3135–3142.PubMedGoogle Scholar
  90. 90.
    Rosen, S. W., and Weintraub, B. D., 1974, Ectopic production of the isolated alpha subunit of the glycoprotein hormones. A quantitative marker in certain cases of cancer, N. Engl. J. Med. 290:1441–1447.PubMedGoogle Scholar
  91. 91.
    Lange, P. H., Mclntire, K. R., Waldmann, T. A., Hakala, T. R., and Fraley, E. E., 1976, Serum alpha feto-protein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer, N. Engl. J. Med. 295:1237–1240.PubMedGoogle Scholar
  92. 92.
    Newlands, E. S., Dent, J., Kardana, A., Searle, F., and Bagshawe, K. D., 1976, Serum a x-fetoprotein and HC G in patients with testicular tumors, Lancet 2:744–745.PubMedGoogle Scholar
  93. 93.
    Kahn, C. R., Rosen, S. W., Weintraub, B. D., Fajans, S. S., and Gorden, P., 1977, Ectopic production of chorionic gonadotropin and its subunits by islet cell tumors: A specific marker for malignancy, N. Engl. J. Med. 297:565–569.PubMedGoogle Scholar
  94. 94.
    Lieblich, J. M., Weintraub, B. D., Rosen, S. W., Chou, J. Y., and Robinson, J. C., 1976, HeLa cells secrete a subunit of glycoprotein tropic hormones, Nature (London) 260:530–532.Google Scholar
  95. 95.
    Maruo, T., 1976, Studies on in vitro synthesis and secretion of human chorionic gonadotropin and its subunits, Endocrinol. Jpn. 23:119–128.PubMedGoogle Scholar
  96. 96.
    Tashjian, A. H., Jr., Weintraub, B. D., Barowsky, N. J., Rabson, A. S., and Rosen, S. W., 1973, Subunits of human chorionic gonadotropin: Unbalanced synthesis and secretion by clonal cell strains derived from a bronchogenic carcinoma, Proc. Natl. Acad. Sci. U.S.A. 70:1419–1422.PubMedGoogle Scholar
  97. 97.
    Weintraub, B. D., Krauth, G., Rosen, S. W., and Rabson, A. S., 1975, Differences between purified ectopic and normal alpha subunits of human glycoprotein hormones, J.Clin. Invest. 56:1043–1052.PubMedGoogle Scholar
  98. 98.
    Livingston, V. W.-C, and Livingston, A. M., 1974, Some cultural immunological and biochemical properties of Progenitor cryptocides, Trans. N.Y. Acad. Sci. 36:569–582.PubMedGoogle Scholar
  99. 99.
    Cohen, H., and Strampp, A., 1976, Bacterial synthesis of substance similar to human chorionic gonadotrophin, Proc. Soc. Exp. Biol. Med. 152:408–410.PubMedGoogle Scholar
  100. 100.
    Braunstein, G. D., Rasor, J., and Wade, M. E., 1975, Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone, N. Engl. J. Med. 293:1339–1343.PubMedGoogle Scholar
  101. 101.
    Yoshimoto, Y., Wolfsen, A. R., and Odell, W. D., 1977, HCG-like substance in normal human tissues, Science 197:575–577.PubMedGoogle Scholar
  102. 102.
    Talwar, G. P., Sharma, N. C., Dubey, S. K., Salahuddin, M., Das, C., Ramakrishnan, S., Kumar, S., and Hingorani, V., 1976, Isoimmunization against human chorionic gonadotropin with conjugates of processed β-subunit of the hormone and tetanus toxoid, Proc. Natl Acad. Sci. U.S.A. 73:218–222.PubMedGoogle Scholar
  103. 103.
    Stevens, V. C., and Crystle, C. D., 1973, Effects of immunization with hapten-coupled HCGon the human menstrual cycle, Obstet. Gynecol. 43:485–495.Google Scholar
  104. 104.
    Talwar, G. P., Dubey, S. K., Salahuddin, M., Das, C., Hingorani, V., and Kumar, S., 1976, Antibody response to Pr-β-HCG-TT vaccine in human subjects, Contraception 13:237–243.PubMedGoogle Scholar
  105. 105.
    Pala, A., Ermini, M., Carenza, L., and Benagiano, G., 1976, Immunization with hapten-coupled hCG β subunit and its effect on the menstrual cycle, Contraception 14:579–593.PubMedGoogle Scholar
  106. 106.
    Hearn, J. P., Short, R. V., and Lunn, S. F., 1976, The effects of immunising marmoset monkeys against the β-subunits of HCG, in: Physiological Effects of Immunity Against Reproductive Hormones (R. G. Edwards and M. H. Johnson, eds.), pp. 229–247, Cambridge University Press, London.Google Scholar
  107. 107.
    Sundaram, K., Chang, C. C., Laurence, K. A., Brinson, A. O., Atkinson, L. E., Segal, S. J., and Ward, D. N., 1976, The effectiveness in rhesus monkeys of an antifertility vaccine based on neutralization of chorionic gonadotropin, Contraception 14:639–653.PubMedGoogle Scholar
  108. 108.
    Stevens, V. C., 1975, Female contraception by immunization with HCG— prospects’ status, in: Immunization with Hormones in Reproduction Research (E. Nieschlag, ed.), pp. 217–231, North-Holland Publishing Co., Amsterdam.Google Scholar
  109. 109.
    Kumar, S., Sharma, N. C., Bajaj, J. S., Talwar, G. P., and Hingorani, V., 1976, Clinical profile and toxicology studies on four women immunized with Pr-β-HCG-TT, Contraception 13:253–268.PubMedGoogle Scholar
  110. 110.
    Nath, I., Wittingham, S., Lambert, P. H., and Talwar, G. P., 1976, Screening for autoantibodies in human subjects immunized with Pr-β-HCG-TT, Contraception 13:225–230.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • Mortimer B. Lipsett
    • 1
  • Griff T. Ross
    • 1
  1. 1.National Institutes of HealthBethesdaUSA

Personalised recommendations